XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flow from / (used in) operating activities    
Net profit / (loss) $ 790 $ 2,136
Non-cash items included in net profit and other adjustments:    
Depreciation, amortization and impairment of non-financial assets 1,162 1,176
Credit loss expense / (release) 136 54
Share of net (profit) / loss of associates and joint ventures and impairment related to associates (40) (25)
Deferred tax expense / (benefit) (355) (63)
Net loss / (gain) from investing activities 162 (116)
Net loss / (gain) from financing activities (2,890) 3,085
Other net adjustments 10,730 (1,198)
Net change in operating assets and liabilities:    
Amounts due from banks and amounts due to banks 2,209 (3,313)
Receivables from securities financing transactions measured at amortized cost 17,828 5,563
Payables from securities financing transactions measured at amortized cost 959 8,109
Cash collateral on derivative instruments (8,503) (5,104)
Loans and advances to customers 5,136 (2,130)
Customer deposits (7,586) (12,733)
Financial assets and liabilities at fair value held for trading and derivative financial instruments (18,195) (7,726)
Brokerage receivables and payables (438) (5,366)
Financial assets at fair value not held for trading and other financial assets and liabilities (17,902) (1,306)
Provisions and other non-financial assets and liabilities 385 658
Income taxes paid, net of refunds (868) (810)
Net cash flow from / (used in) operating activities (17,282) (19,110)
Cash flow from / (used in) investing activities    
Cash and cash equivalents obtained due to the merger of UBS AG and Credit Suisse AG 121,258  
Disposal of subsidiaries, associates and intangible assets 33 35
Purchase of property, equipment and software (691) (669)
Disposal of property, equipment and software 3 0
Net (purchase) / redemption of financial assets measured at fair value through other comprehensive income 369 24
Purchase of debt securities measured at amortized cost (1,850) (7,541)
Disposal and redemption of debt securities measured at amortized cost 4,848 4,659
Net cash flow from / (used in) investing activities 123,971 (3,492)
Cash flow from / (used in) financing activities    
Repayment of Swiss National Bank funding (10,304)  
Net issuance (repayment) of short-term debt measured at amortized cost (2,140) 5,555
Distributions paid on UBS AG shares (3,000) (6,000)
Issuance of debt designated at fair value and long-term debt measured at amortized cost 60,796 51,141
Repayment of debt designated at fair value and long-term debt measured at amortized cost (59,139) (44,091)
Inflows from securities financing transactions measured at amortized cost 2,863  
Net cash flows from other financing activities (246) (242)
Net cash flow from / (used in) financing activities (11,170) 6,362
Total cash flow    
Cash and cash equivalents at the beginning of the period 190,469 195,200
Net cash flow from / (used in) operating, investing and financing activities 95,520 (16,239)
Effects of exchange rate differences on cash and cash equivalents (8,472) 1,999
Cash and cash equivalents at the end of the period 277,517 180,959
of which: cash and balances at central banks 248,335 159,343
of which: amounts due from banks 18,365 12,189
of which: money market paper 10,816 9,428
Net cash flow from / (used in) operating activities includes:    
Interest received in cash 20,832 15,024
Interest paid in cash 18,345 11,429
Dividends on equity investments, investment funds and associates received in cash $ 1,505 $ 1,259